were prevalent across both market segments (price). Clinics are important locations for deciding to complete the vaccine series (place). They are the preferred sources to obtain information about the HPV vaccine thus making them ideal locations to deliver intervention messages, followed by television, the child's school and brochures (promotion). Increasing HPV vaccine coverage among Hispanic adolescents will reduce the rates of HPV-associated cancers and the cervical cancer health disparity among Hispanic women. This research can inform the development of an intervention to increase HPV vaccine series completion in this population.
Introduction
The human papillomavirus (HPV) vaccine is recommended by the Advisory Committee on Immunization Practices for females and males who are between 9 and 26 years old [1] . It is a 3-dose series that should be administered over sixmonths [1] and provides protection against certain cancercausing HPV types including 16, 18, 31, 33, 45, 52 and 58 [1] . These HPV types can cause cervical, vulvar, vaginal, anal and oropharyngeal cancer in females; and penile, anal and oropharyngeal cancer in males [1] [2] [3] . The incidence of HPV-associated oropharyngeal and anal cancer in the US is currently on the rise [4, 5] . Further, a cervical cancer disparity among Hispanic women in this country still exists [6] .
Vaccinating against HPV will significantly reduce the incidence of HPV-associated cancers. As such, the Healthya convenience sample of participants from community sites including community centers and clinics in Houston, Texas. Eligibility criteria included identifying as Hispanic or Latino, speaking Spanish as a primary language and having a child between 11 and 17 years of age who had initiated the HPV vaccine series. We included mothers whose child had initiated, but not completed the HPV vaccine series along with mothers whose child had completed the vaccine series in order to identify the perspectives of both and increase our knowledge of the behavior [16] . Participants were classified according to two market segments, based on their HPV vaccination status: Initiated: daughter or son had received at least one dose of the HPV vaccine and Completed: daughter or son had completed the three-dose HPV vaccine series. Our sample consisted of 16 mothers of Initiated girls; 12 mothers of Initiated boys; 16 mothers of Completed girls; and 7 mothers of Completed boys.
Procedure
All of the procedures we describe were approved by the Institutional Review Board at the University of Texas Health Science Center-Houston (protocol number: HSC-SPH-13-0594). Women were approached in Spanish and given a brief oral description of the study. We explained the purpose of the study, eligibility criteria, length of the interview and incentive amount. Those who met eligibility criteria and were interested in participating, were consented. Participants completed a brief demographic survey. Then, the interviews were conducted and audio-recorded by female research staff. Each interview took approximately 20 min to complete. Mothers were compensated $20 for their participation.
Interview Instrument and Data Analysis
Based on a literature review, we created interview guides for mothers for each different market segment. The interview guides consisted of open-ended questions designed to elicit responses related to product, price, placement and promotion [9, 17] (Promotion) . The majority of the interview questions were similar across the market segments, with differences related to the child's HPV vaccine status (i.e., Initiated or Completed). 80 % among adolescents between the ages of 13 and 17 [7] . However, vaccine completion rates among Hispanic females and males between the ages of 13 and 17 in 2014 were an estimated 39.3 and 21.1 % [8] . These low vaccine series completion rates suggest the need to develop effective interventions that promote completion among Hispanic adolescents.
Social marketing is a conceptual framework that can be used to develop an intervention to increase HPV vaccine series completion. This framework applies concepts and techniques from commercial marketing to develop interventions [9, 10] . The fundamental principles of this framework are known as the marketing mix or more commonly referred to as the four Ps: product, price, place and promotion [9, 11] . The benefits of a given behavior are the product. The potential costs associated with the behavior are the price. The location where the behavior will occur and individuals or entities that provide information or other goods that facilitate the behavior are the place. The important features or components of designing and delivering messages about the behavior is the promotion. To date, social marketing has been applied to maintaining a healthy diet [12] , increasing physical activity [13] , and breastfeeding [14] . However, it has not yet been applied to understand and assess what factors influence Hispanic mothers' decision to have their adolescent child complete the HPV vaccine series. Therefore, the purpose of the current study is to identify the key elements of social marketing (i.e., the four Ps: product, price, place and promotion) that are necessary for planning and implementing an HPV intervention to increase vaccine series completion in Hispanic adolescents.
Methods
We employed a qualitative research design of in-depth interviews because they allowed us to gain a deeper understanding of Hispanic mothers' culturally specific values, attitudes, and beliefs related to HPV vaccine series completion using a social marketing framework. In-depth interviews were chosen, since we were collecting information about personal history, perspectives and experiences [15] . Using Grier and Bryant's [9] definitions of the 4 P's, we developed operational definitions for product, price, place, and promotion as related to Hispanic mothers having their adolescent children complete the HPV vaccine series.
Participants
From May 2014 through January 2015, we conducted 51 in-depth interviews with Spanish-speaking Hispanic mothers of adolescent girls and boys aged 11 to 17. We recruited that vaccinating is necessary; seeing a television story about a young woman with HPV ( Mothers in the Initiated market segment mentioned ten positive effects/benefits of having their child complete the HPV vaccine series ( Table 2 ). The most frequently cited was: the vaccine is good for their child's health. As one mother explained, "The positive effects of completing the series are the same as when I gave him the other two doses. Completing the series will be good for his health." Other reasons mentioned included: the child will be up-to-date with needed vaccinations; to prevent illness; to protect their child from illness; to improve their child's behavior; the vaccine cures cervical cancer; the vaccine cures other illnesses; for better health for the child and for a better future for the child. The Completed market segment mentioned fewer benefits of vaccine series completion ( Table 2 ). The most frequently mentioned benefit was: to prevent illness. One mother stated, "It is the security of knowing that I don't have to worry about another dose and being certain that she will be well…and that we have prevented HPV." Other benefits included: to protect their child from illness; the vaccine is good for their child's health; to protect child's future partner from HPV that causes cervical cancer; security in knowing that the vaccine will keep child healthy; everything about the vaccine is good; and the vaccine will work as it is meant to.
Price
Regarding potential costs to completing the vaccine series, no was the first and second most mentioned response by Completed and Initiated mothers, respectively. As one Completed mother stated, "No, there were no complications of any kind to completing the vaccine series." Initiated mothers listed the following barriers: no health insurance; not having money to pay for the vaccine; high cost or price of the vaccine; no time to take child to be vaccinated; difficulty vaccinating during the school year; difficulty keeping the vaccination appointment; no transportation; uncertainty about the number of doses the child has received; child not agreeing to be vaccinated; lack of information about the vaccine; child being sick during the clinic visit; and mistrust or discomfort with clinic personnel (Table 3) . Completed Interviews were transcribed verbatim by a transcriptionist. We followed Middlestadt and colleagues' recommendations for collecting and analyzing qualitative elicitation interview data [16] . We employed directed qualitative content analysis [18] to classify and rank the responses for each question. The primary author read through all of the transcripts several times to obtain a sense of the data. Then, she read the transcripts line-by-line, highlighting the words and making notes of words that captured the relevant themes discussed for each key concept (i.e., the 4 P's). Themes were created by first, assigning concepts to key words or phrases. Then the concepts were sorted into categories and organized into themes. Similar concepts that were grouped together were named with a particular theme. Through this process, a list of codes for each theme emerged. The interview transcripts were then independently coded for themes by three coders, including the primary author. Transcripts were coded in groups by child's gender and HPV vaccination status (e.g., group 1: all mothers of girls who had received one dose of the HPV vaccine). Interrater reliability for theme coding was calculated using the kappa statistic, which exceed 0.79 for all pairs of coders. All discrepancies between the three coders' theme counts were examined, discussed and resolved. Then, we combined the group counts by market segment (i.e., Initiated and Completed) for each key concepts and calculated the frequencies and percentages for the theme counts were calculated to determine the number of responses mentioned by each market segment.
Results
Sixty-one percent of participants were 40 year old or older (mean = 42.1; SD = 6.0). Most were married (68.6 %), had not completed high school (78.4 %) and were foreign born (98 %) with 60.8 % reporting being born in Mexico. Only 9.8 % of the children did not have health insurance coverage with 84.3 % being covered by government subsidized health insurance. Regarding age, 21.6 % were between 11 and 12 years old, 49 % between 13 and 15 years old and 29.4 % between 15 and 17 years old.
Product
The desire to complete the vaccine series emerged as the most frequently cited reason mothers in the Initiated market segment would have their child complete the vaccine series. As a mother stated, "I want him to complete the series because it is good for him and since he's had two doses already, he needs to complete the series." Other reasons cited included: receiving vaccine reminders; to prevent illness; to protect their child from illness; speaking with the doctor about vaccinating; they had already decided to vaccinate; knowing Completed mothers mentioned the benefits of vaccinating most frequently. As one mother explained, "A pamphlet that they gave me at the clinic, where I read all the pros and cons about the vaccine, provided the information I needed." Other informational needs included: vaccine dosing schedule; vaccine safety and side effects; purpose of the vaccine; information about HPV; vaccine reminders; general vaccine information; and seeing that the child does not have a reaction to the vaccine (Table 4) . No informational barriers was a response given by only 2 Initiated mothers and 4 Completed mothers.
Place
The clinic was the place where most mothers in both market segments heard about the HPV vaccine for the first time (Table 5 ). For Initiated mothers this was followed by: the child's school; the television; a friend or a relative. After the clinic, Completed mothers reported hearing about the vaccine series: at the child's school; on television; and in the newspaper. There were two Completed mothers who had not heard of the vaccine before the interview. mothers cited the following barriers: no health insurance; no transportation; not having money to pay for the vaccine; high cost or price of the vaccine; difficulty keeping the vaccination appointment; child not agreeing to be vaccinated; child is not strong enough to receive the vaccine; the injection is painful; vaccine not being in stock at the clinic; lack of father's support for vaccination; lack of information about the vaccine; not knowing where the child can be vaccinated; and child is sick during the clinic visit ( Table 3) .
The Initiated market segment mentioned more informational barriers to HPV vaccine completion compared to the Completed market segment (13 versus 8). They included: a need for general information about the vaccine. "I would like to have all of the information available about the vaccine." Other informational barriers mentioned were: the number of vaccine doses their child has already received and how many more are needed; the purpose of the vaccine; vaccine safety and side effects; cost of the vaccine; benefits of vaccinating; vaccine dosing schedule; how to ensure that their child receives all doses; what the vaccine prevents; vaccine reminders; information about HPV; where the child can be vaccinated; having child's immunization card (Table 4) . Responses may not add up to N due to some participants providing multiple responses complete HPV vaccine series. The desire to protect their child from illness or prevent illness were two major factors. Speaking with the doctor about vaccination was another and reinforces the importance of doctors in the health decisions that parents make for their children [19, 20] . For Initiated mothers, we found that the desire to complete the vaccine series was important. This along with the Completed segment's mention of the desire to stay current with new health developments for their children can be incorporated into a single intervention message. We found that vaccine reminders would also help mothers decide to have their child complete the vaccine series. Given the well-established effectiveness of vaccine reminders on vaccination [21] [22] [23] they should be included in HPV vaccine completion interventions.
Regarding the perceived positive effects or benefits of having their child complete the HPV vaccine series, both
Promotion
Both market segments prefer to seek information about the HPV vaccine from the clinic ( Table 6 ). The remaining preferred information sources for Initiated mothers were: the Internet; the telephone; a community center; and mailed information. The remaining preferred information sources for Completed mothers were: the television; the child's school; and a brochure.
Discussion Product
We identified several factors, common to both market segments, which influence the decision to have their child Responses may not add up to N due to some participants providing multiple responses opportunity to educate their child about maintaining good health practices. This novel finding represents a potential motivating factor of vaccine series completion that is not health related. In sum, the findings regarding product market segments mentioned that the vaccine would protect their child from illnesses, prevent illnesses and that the HPV vaccine is good for their child's health. According to the Initiated mothers, completing the vaccine provides an Responses may not add up to N due to some participants providing multiple responses barriers to vaccine series completion were related to keeping the vaccination appointments. This is a particularly important barrier to address given that the vaccine series completion involves three separate trips to the clinic. According to Initiated mothers, uncertainty about the number of HPV vaccine doses their child has received is a potential barrier to series completion. This suggests the need to equip mothers with the efficacy to obtain this information from their child's immunization record or the clinic. Mothers in the Initiated market segment also mentioned that their child not agreeing to be vaccinated was a barrier. It is important to provide mothers with the skills to communicate the benefits and importance of vaccination along with how to address their child's concerns. Comparatively, Initiated mothers noted more potential barriers to having their child complete the HPV vaccine series compared to Completed mothers. Despite the higher provide guidance regarding the types of benefits, healthrelated and non-health related, that should be emphasized by interventions. Future studies might further explore the implicit non-health related reasons for vaccine completion.
Price
Consistent with existing literature we found that not having health insurance [24] , the cost of the vaccine [3, 26] , and transportation [27] were perceived barriers (costs) to vaccine series completion. As such, it is recommended that intervention messages reinforce that fact that there are existing programs (e.g., Vaccines for Children) to cover the cost. Interventions should provide strategies to overcome transportation difficulties, such as informing mothers of mobile clinics that vaccinate outside of elementary schools and other locations around the community. Several potential Responses may not add up to N due to some participants providing multiple responses vaccine from the clinic (community communication method); followed by child's school and community center. The Internet, by mail, television and brochures were the preferred public/mass communication methods of promotion. The telephone was the only interpersonal communication method mentioned. While research supports the Internet as a promising information delivery method for the HPV vaccine [30] , future research should explore the relative effectiveness of these methods. Some Initiated mothers did not know where to seek information unlike Completed mothers who appear certain of where to seek information. As such, it is important provide mothers with details and options about where they can go to receive trusted information about the HPV vaccine before or during the dose administrations. Clinic personnel should also be prepared to provide accurate and understandable HPV vaccine information for this population. The use of multiple communication methods to disseminate messages will potentially increase the salience of and reinforce the importance of HPV vaccine completion. In turn, this may lead to higher completion rates in this population.
Limitations of the study should be mentioned. First, our sample consisted of Spanish-speaking Hispanic mothers. Therefore, our finding may not generalize to non-Spanish speaking or non-Hispanic mothers. Secondly, since we employed convenience sampling, there is the potential for selection bias. Additionally, as with all self-report data, there is the possibility that our participants' responses were influenced by social desirability. Finally, there is the possibility of interviewer bias. To minimize the potential effect of interviewer bias, our interviewers received extensive training and we also employed a structured interview guide.
Our findings highlight the importance of removing informational barriers along with the central role of the clinic and clinic personnel in ensuring that adolescent Hispanics complete the HPV vaccine series. We also identified other sources that can be employed to disseminate messages promoting the behavior. This formative research represents the first step in the development of a social marketing theorybased intervention to increase HPV vaccine series completion among Hispanic adolescents.
number of potential barriers cited by Initiated mothers, "no barriers to vaccine series completion" was the second most frequent response for this group and the most frequent response for Completed mothers. This suggests two things: (1) most Initiated mothers do not expect to encounter barriers to vaccine series completion and (2) in practice, most mothers do not encounter barriers that prevent completion. Future research might further investigate the perceived vs. experiential (actual) barriers.
Compared to general perceived barriers, we found that informational barriers to vaccine series completion were more prevalent. Some informational barriers that emerged overlapped with previously discussed barriers (e.g., cost, vaccine reminders and number of doses of the vaccine child has already received). The prevalence of informational barriers is supported in the existing literature [27] and suggests a need to disseminate intervention messages that address these barriers. It is recommended that promotional messages discuss or outline common answers to the informational barriers.
Place
There are five different types of communication methods: intrapersonal, interpersonal, organizational, community and public/mass [28] . Overall, we found that community communication methods are preferred by both market segments. The clinic (community communication method) was, by far, where most mothers in both market segments heard about the HPV vaccine for the first time and made the initial decision to vaccinate. This is supported by previous research [29] and suggests that clinics are likely the best place to convince Hispanic mothers to have their children complete the HPV vaccine series. In addition to confirming clinics as a primary location where mothers decide to have their child complete the HPV vaccine series, we also identified other potential locations. The child's school, another community communication method, emerged as the second best place to encourage these mothers to have their children complete the series. We also identified television (public/mass communication method), friends and relatives (both interpersonal communication methods) and the newspaper (community communication method). These findings provide guidance regarding potential locations, aside from clinics, which can be used to encourage mothers to think about having their child complete the HPV vaccine series.
Promotion
Our findings provide needed guidance for interventions regarding which sources Hispanic mothers prefer and trust. While Initiated mothers mentioned more preferred information sources compared to Completed mothers, by far, both market segments will seek information about the HPV
